advertising
-
1
Shear MS, Baitch SP, Shear DB: Sinus tarsi syndrome: the importance of biomechanically-based evaluation and treatment. Arch Phys Med Rehabil 74: 777, 1993.
-
2
Taillard W, Meyer J-M, Garcia J, et al.: The sinus tarsi syndrome. Int Orthop 5: 117, 1981.
-
3
Helgeson K: Examination and intervention for sinus tarsi syndrome. N Am J Sports Phys Ther 4: 29, 2009.
-
4
Nyska M, Mann G, eds: “Sinus Tarsi Syndrome,” in The Unstable Ankle, p 114, Human Kinetics, Champaign, IL, 2002.
-
5
O'Connor D: Sinus tarsi syndrome: clinical entity. J Bone Joint Surg 40: 720, 1958.
-
6
Claustre J, Simon L, Allieu Y: Le syndrome du sinus du tarse existe-t-il. Rheumatologie 31: 19, 1979.
-
7
Borrelli AH, Arenson DJ: Sinus tarsi syndrome and its relationship to hallux abducto valgus. JAPMA 77: 495, 1987.
-
8
Arias C, Abdulle SA, Wagner J: Conception actuelle du sinus du tarse. RévMéd Brux 7: 323, 1986.
-
9
Schwarzenbach B, Dora C, Lang A, et al.: Blood vessels of the sinus tarsi and the sinus tarsi syndrome. Clin Anat 10: 173, 1997.
-
10
Pisani G, Pisani PC, Parino E: Sinus tarsi syndrome and subtalar joint instability. Clin Podiatr Med Surg 22: 63, 2005.
-
11
Frey C, Feder KS, DiGiovanni C: Arthroscopic evaluation of the subtalar joint: does sinus tarsi syndrome exist? Foot Ankle Int 20: 185, 1999.
-
12
Roemer FW, Jomaah N, Niu J, et al.: Ligamentous injuries and the risk of associated tissue damage in acute ankle sprains in athletes: a cross-sectional MRI study. Am J Sports Med 42: 1549, 2014.
-
13
Fong DT-P, Hong Y, Chan L-K, et al.: A systematic review on ankle injury and ankle sprain in sports. Sports Med 37: 73, 2007.
-
14
Al-Mohrej OA, Al-Kenani NS: Chronic ankle instability: current perspectives. Avicenna J Med 6: 103, 2016.
-
15
Sugimoto K, Isomoto S, Samoto N, et al.: Recent developments in the treatment of ankle and subtalar instability. Open Orthop J 11: 687, 2017.
-
16
Waterman BR, Owens BD, Davey S, et al.: The epidemiology of ankle sprains in the United States. J Bone Joint Surg Am 92: 2279, 2010.
-
17
McCulloch P, Holden P, Robson D, et al.: The value of mobilisation and non-steroidal anti-inflammatory analgesia in the management of inversion injuries of the ankle. Br J Clin Pract 39: 69, 1985.
-
18
Brooks S, Potter B, Rainey J: Treatment for partial tears of the lateral ligament of the ankle: a prospective trial. Br Med J (Clin Res Ed) 282: 606, 1981.
-
19
Ruth CJ: The surgical treatment of injuries of the fibular collateral ligaments of the ankle. J Bone Joint Surg 43: 229, 1961.
-
20
Soboroff SH, Pappius EM, Komaroff AL: Benefits, risks, and costs of alternative approaches to the evaluation and treatment of severe ankle sprain. Clin Orthop Relat Res 183: 160, 1984.
-
21
Perlman M, Leveille D, DeLeonibus J, et al.: Inversion lateral ankle trauma: differential diagnosis, review of the literature, and prospective study. J Foot Surg 26: 95, 1987.
-
22
Fallat L, Grimm DJ, Saracco JA: Sprained ankle syndrome: prevalence and analysis of 639 acute injuries. J Foot Ankle Surg 37: 280, 1998.
-
23
Hong-Geun J: Foot and Ankle Disorders: An Illustrated Reference, Springer, Berlin, 2016.
-
24
Østergaard M, Halberg P: Intra-articular corticosteroids in arthritic disease. BioDrugs 9: 95, 1998.
-
25
Hench PS, Kendall EC, Slocumb CH, et al.: The effect of a hormone of the adrenal cortex (17-hydroxy-11-dehydrocorticosterone: compound E) and of pituitary adrenocortical hormone in arthritis: preliminary report. Ann Rheum Dis 8: 97, 1949.
-
26
Lapidus P, Guidotti F: Local injections of hydrocortisone in 495 orthopedic patients. Ind Med Surg 26: 234, 1957.
-
27
Jessar RA, Ganzell MA, Ragan C: The action of hydrocortisone in synovial inflammation. J Clin Invest 32: 480, 1953.
-
28
Nilsson S: Sprains of the lateral ankle ligaments. J Oslo City Hosp 33: 13, 1983.
-
29
Vannini F, Di Matteo B, Filardo B: G: Platelet-rich plasma to treat ankle cartilage pathology—from translational potential to clinical evidence: a systematic review. J Exp Orthop 2: 2, 2015.
-
30
Trescot A, Pearce B: “Ankle and Foot, and Related Joints, Ligaments and Tendons,” in Essentials of Regenerative Medicine in Interventional Pain Management, p 369, ASIPP Publishing, Paducah, KY, 2019.
-
31
Laver L, Carmont MR, McConkey MO, et al.: Plasma rich in growth factors (PRGF) as a treatment for high ankle sprain in elite athletes: a randomized control trial. Knee Surg Sports Traumatol Arthrosc 23: 3383, 2015.
-
32
Mishra A, Tummala P, King A, et al.: Buffered platelet-rich plasma enhances mesenchymal stem cell proliferation and chondrogenic differentiation. Tissue Eng Part C Methods 15: 431, 2009.
-
33
McCartney-Francis NL, Song X-Y, Mizel DE, et al.: Selective inhibition of inducible nitric oxide synthase exacerbates erosive joint disease. J Immunol 166: 2734, 2001.
-
34
Stefanovic‐Racic M, Meyers K, Meschter C, et al.: N‐monomethyl arginine, an inhibitor of nitric oxide synthase, suppresses the development of adjuvant arthritis in rats. Arthritis Rheum 37: 1062, 1994.
-
35
Sakurai H, Kohsaka H, Liu M-F, et al.: Nitric oxide production and inducible nitric oxide synthase expression in inflammatory arthritides. J Clin Invest 96: 2357, 1995.
-
36
McInnes IB, Leung BP, Field M, et al.: Production of nitric oxide in the synovial membrane of rheumatoid and osteoarthritis patients. J Exp Med 184: 1519, 1996.
-
37
Komprda J: Le syndrome du sinus du tarse. Ann Podol 5: 11, 1966.
-
38
Kuwada G: Long-term retrospective analysis of the treatment of sinus tarsi syndrome. J Foot Ankle Surg 33: 28, 1994.
-
39
Willems F, Weir A, van de Werve M, et al.: Etiologie, diagnostiek en behandeling van het sinus tarsi-syndroom. Sport en Geneeskd 44: 26, 2011.
-
40
Nyska M, Mann G, eds: The Unstable Ankle, Human Kinetics, Champaign, IL, 2002.
-
41
Klausner VB, McKeigue ME: The sinus tarsi syndrome: a cause of chronic ankle pain. Phys Sportsmed 28: 75, 2000.
-
42
Kon E, Buda R, Filardo G, et al.: Platelet-rich plasma: intra-articular knee injections produced favorable results on degenerative cartilage lesions. Knee Surg Sports Traumatol Arthrosc 18: 472, 2010.
-
43
Erdine S: Ağrı, Nobel Tıp Kitabevleri, Alemdar Ofset Savaş Ciltevi, Istanbul, 2000.
-
44
Akbaba YA, Celik D, Ogut RT: Translation, cross-cultural adaptation, reliability, and validity of Turkish version of the American Orthopaedic Foot and Ankle Society Ankle-Hindfoot Scale. J Foot Ankle Surg 55: 1139, 2016.
-
45
Yalıman A, Şen Eİ, Eskiyurt N, et al.: Ayak Fonksiyon Indeksi’nin plantar fasiitli hastalarda Türkçe’ye çeviri ve adaptasyonu. Turk J Phys Med Rehabil 60: 212, 2014.
-
46
Karatepe AG, Günaydın R, Kaya T, et al.: Validation of the Turkish version of the Foot and Ankle Outcome Score. Rheumatol Int 30: 169, 2009.
-
47
Boonstra AM, Preuper HRS, Reneman MF, et al.: Reliability and validity of the visual analogue scale for disability in patients with chronic musculoskeletal pain. Int J Rehabil Res 31: 165, 2008.
-
48
Ibrahim T, Beiri A, Azzabi M, et al.: Reliability and validity of the subjective component of the American Orthopaedic Foot and Ankle Society clinical rating scales. J Foot Ankle Surg 46: 65, 2007.
-
49
Madeley NJ, Wing KJ, Topliss C, et al.: Responsiveness and validity of the SF-36, Ankle Osteoarthritis Scale, AOFAS Ankle Hindfoot Score, and Foot Function Index in end stage ankle arthritis. Foot Ankle Int 33: 57, 2012.
-
50
Agel J, Beskin JL, Brage M, et al.: Reliability of the Foot Function Index: a report of the AOFAS Outcomes Committee. Foot Ankle Int 26: 962, 2005.
-
51
Roos EM, Brandsson S, Karlsson J: Validation of the foot and ankle outcome score for ankle ligament reconstruction. Foot Ankle Int 22: 788, 2001.
-
52
Faul F, Erdfelder E, Buchner A, et al.: Statistical power analyses using G* Power 3.1: tests for correlation and regression analyses. Behav Res Methods 41: 1149, 2009.
-
53
Kirkpatrick LA, Feeney BC: A Simple Guide to IBM SPSS: For Version 22.0, Cengage Learning, Boston, 2014.
-
54
Ferkel RD, Karzel RP, Del Pizzo W, et al.: Arthroscopic treatment of anterolateral impingement of the ankle. Am J Sports Med 19: 440, 1991.
-
55
Scranton P: Arthroscopic treatment of symptomatic anterior ankle impingement lesions in the athlete. Sports Med Arthrosc Rev 2: 289, 1994.
-
56
Klein M, Spreitzer A: MR imaging of the tarsal sinus and canal: normal anatomy, pathologic findings, and features of the sinus tarsi syndrome. Radiology 186: 233, 1993.
-
57
Fried A, Dobbs BM: Sinus tarsi synovectomy: a possible alternative to a subtalar joint fusion. JAPMA 75: 494, 1985.
-
58
Samra DJ, Sman AD, Rae K, et al.: Effectiveness of a single platelet-rich plasma injection to promote recovery in rugby players with ankle syndesmosis injury. BMJ Open Sport Exerc Med 1: e000033, 2015.
-
59
Moretti M: Effectiveness of hyaluronic acid and O2-O3 injections in lateral ankle sprains without tear of anterior talofibular ligament. Int J Ozone Ther 11: 98, 2012.
Corticosteroid, Platelet-Rich Plasma, and Ozone Injections for Sinus Tarsi Syndrome
Search for other papers by Serdar Toy in
Current site
Google Scholar
PubMed
Search for other papers by Kutsi Tuncer in
Current site
Google Scholar
PubMed
Search for other papers by Murat Topal in
Current site
Google Scholar
PubMed
Search for other papers by Ali Aydın in
Current site
Google Scholar
PubMed
Background: Sinus tarsi syndrome is characterized by permanent pain on the anterolateral side of the ankle due to chronic inflammation characterized by fibrotic tissue remnants and synovitis accumulation after repeated traumatic injuries. Few studies have documented the outcome of injection treatments for sinus tarsi syndrome. We sought to determine the effects of corticosteroid and local anesthetic (CLA), platelet-rich plasma (PRP), and ozone injections on sinus tarsi syndrome.
Methods: Sixty patients with sinus tarsi syndrome were randomly divided into three treatment groups: CLA, PRP, and ozone injections. Outcome measures were visual analog scale, American Orthopedic Foot and Ankle Society Ankle-Hindfoot Scale (AOFAS), Foot Function Index, and Foot and Ankle Outcome Score before injection compared with 1, 3, and 6 months after injection.
Results: At the end of months 1, 3, and 6 after injection, significant improvements were observed in all three groups compared with baseline (P < .001 for all). At months 1 and 3, improvements in AOFAS scores were similar in the CLA and ozone groups; those in the PRP group were lower (P = .001 and P = .004, respectively). At month 1, improvements in Foot and Ankle Outcome Score were similar in the PRP and ozone groups and higher in the CLA group (P < .001). At 6-month follow-up, there were no significant differences in visual analog scale and Foot Function Index results among the groups (P > .05).
Conclusions: Ozone, CLA, or PRP injections could provide clinically significant functional improvement for at least 6 months in patients with sinus tarsi syndrome.
advertising
